CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lung transplant patients: drug combo aims to knock out CMV faster
Disease control Recruiting nowThis study tests whether adding the drug letermovir to standard antiviral treatment helps clear cytomegalovirus (CMV) infection faster in people who have received a lung transplant. About 40 participants will receive either the combination or standard care plus a placebo. The goa…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Can a simple antibody shot shield kidney transplants from a dangerous virus?
Prevention Recruiting nowThis study is testing whether a drug called CMVIG can prevent CMV infection in kidney transplant patients who are switching to a new anti-rejection medicine (belatacept). About 30 adults who are CMV-negative but received a kidney from a CMV-positive donor will take part. Research…
Matched conditions: CMV
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Prevention
Last updated May 26, 2026 02:48 UTC
-
New hope for transplant patients: extended drug course may stop dangerous virus
Prevention Recruiting nowThis study tests whether taking letermovir for a longer time (up to 28 weeks) can prevent cytomegalovirus (CMV) infection in 330 high-risk Chinese adults who have received a stem cell transplant. CMV is a common and serious complication in these patients because their immune syst…
Matched conditions: CMV
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated May 11, 2026 20:39 UTC
-
Why do some people suffer severe viral infections? scientists investigate immune defects
Knowledge-focused Recruiting nowThis study looks at people who have had unusually severe or long-lasting viral infections, like serious cases of herpes, HPV, or CMV. Researchers want to find out if problems in the immune system or genes are to blame. Up to 600 participants and their relatives will provide blood…
Matched conditions: CMV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 03:05 UTC